We aim to foster a culture of entrepreneurship, innovation and success among engineers in the UK, creating economic growth and societal impact. At the heart of how we do this are the Hub Members, the promising entrepreneurs who we support through our programmes, and our Hub Mentors, the business leaders who volunteer their expertise and time to help the Hub Members succeed.
From manufacturing to medtech, our Hub Membership is made up of some of the UK’s most innovative entrepreneurs. But don’t just take our word for it: read more about our Hub Members to see how they are, without exaggeration, changing the world.
Commercial drones are now being used for several different roles such as mapping farms, inspecting buildings and search-and-rescue operations. Most commercial drone automation software on the market is generic, meaning drone operators and enterprises requiring customised solutions are forced to use many different types of software to get their job done. This becomes incredibly expensive and unreliable.
Hammer Flights Ltd is the world’s first adaptive flight automation software for unmanned aerial vehicles. It is highly versatile, supporting many different types of flight automation and yet is extremely simple to use. Using modular software architecture and APIs , the software morphs according to the task at hand.
Hammer aims to empower every drone operation in the world with adaptive flight automation to make their operations more productive, creative and safe. Its next key milestone is to understand how it can scale its enterprise offerings over the next 12 to 18 months.
The commercial drone industry is currently worth $13 billion and is expected to grow to $45 billion by 2025. A lot of this growth is attributed to enterprises rapidly setting up in-house drone teams and integrating drones into their existing workflows. Each one of these businesses will be looking for a customised flight automation solution that adapts to the needs of their business.
Hammer is currently grant funded by Ordnance Survey – the UK’s largest mapping agency – and the Royal Academy of Engineering through its Enterprise Fellowship programme. It has also formed strategic partnerships within the drone ecosystem.
“The Enterprise Fellowship has provided us with an amazing network of fellow entrepreneurs and mentors that we can learn from throughout our journey.”
Co-founder and Chief Science Officer, Adaptix Ltd
ViBo Health is a startup that will offer some of the benefits of traditional laboratory tests without needing to give blood and wait for the meta-analysis. The company is working on instrumentation that will scan a person’s wrist using hardware based on magnetic resonance spectroscopy (MRS), combined with advanced signal processing and machine learning.
The 10-second scan, using non-invasive molecular spectroscopy, will provide real-time analysis of various metabolic measurements. When used regularly, this data will show an individual’s health trends by outlining changing vitamin levels, cholesterols and diabetes parameters.
ViBo Health intends to place scanners in high-traffic venues such as gyms and pharmacies. As well as giving users an insight into their own health and fitness status, the anonymised data would be of use to clinicians and health workers to analyse more general health trends.
Dr Gil Travish co-founded ViBo Health in 2020. He became an SME Leader in 2017, when he was Chief Science Officer at Adaptix, another company that he co-founded. Gil says that the SME Leaders programme “has been instrumental in my development as a founder and leader of startups. With ViBo Health, it has helped me with networking and defining the company through multiple roundtables.”
The company’s current aim is to focus on formal product definition and gain a fuller understanding of the market. ViBo Health Europe has already received support from the European Space Agency Business Incubation Centre in Portugal and the European Institute of Innovation and Technology. It is now working on several grant applications and hoping to bring in new investors.
“[The SME leaders programme] has been instrumental in my development as a founder and leader of startups. With ViBo Health, it has helped me with networking and defining the company through multiple roundtables.”
MediSieve has developed
magnetic blood filtration, a unique tool that enables doctors to selectively
remove harmful substances directly from a patient’s bloodstream. Practically
any target can be removed including specific cells, inflammatory cytokines,
pathogens and antibodies, providing a platform to treat a huge range of medical
conditions and accessing billion-dollar global markets.
The MediSieve Filter is a single-use, disposable magnetic filter that can capture and retain magnetic components. It can filtrate large quantities of blood quickly, with only a small volume outside the patient’s body at any one time, enabling most treatments to be performed in two to three hours.
Dr Cristina Blanco-Andujar is the CTO for MediSieve, where she leads its internal research development and contributes to clinical trials’ setup. Cristina became an SME Leader in 2018 and says: “The programme has helped me to know myself better as a leader. I have gained the skills and confidence to become a better manager, indeed, I would not have been able to face all the challenges of growing the company without its constant support.”
In 2020, MediSieve, found itself working on a number of different fronts. Although solutions are being developed for a broad range of medical conditions, including leukaemia and malaria, MediSieve’s current focus is on dysregulated immune responses or hyperinflammation. Dysregulated immune reactions, often called cytokine storms, are significant drivers of severity and mortality across a large number of diseases, including sepsis and viral infections such as COVID-19.
MediSieve is currently using its sepsis research to help tackle the high levels of inflammatory cytokine interleukin (IL-6) in the blood of COVID-19 patients. With several UK grants totalling £3 million, MediSieve has pivoted its focus to accelerate the testing of its anti-IL-6 product. This could eventually be used to treat the symptoms of severe COVID-19 patients.
Belfast-based company Axial3D transforms CT and MRI scans into physical 3D printed models for surgeons to use in planning critical surgery in orthopaedics, cardiology and neurology. These patient-specific medical models take 24 to 48 hours to make, giving surgeons much greater insight into a patient than they would get from 2D scans. Surgeons using these models for complex operations say that they change pre-operative plans for half of patients, enabling time and money savings in most surgeries.
Niall Haslam is the CTO at Axial3D, responsible for the company’s research and development activities. Niall became an SME Leader in 2018 and credits the programme with helping to grow
his team. He says: “Engineers are used to solving problems. The Academy’s courses helped me take a step back from our research work and learn how to contribute to the company strategy in other ways. I have been able to do this both from a technical point of view, and financial too.”
Axial3D is expanding rapidly with a doubling of staff numbers in just two years as it has transitioned from startup to a scale-up company. It has been able to attract funding from Innovate UK to validate the use of its models in pre-operative planning. This has been especially useful in helping address surgical waiting lists caused by the COVID-19 pandemic. Surgeons have found that they can save 62 minutes per case on average when using a 3D model to plan a procedure.
Niall says that the US healthcare market has recently become even more important to Axial3D. It has been involved in a number of collaborative projects there and is continuing to grow its presence and sales in the region.
VOID have developed VO+, a patented technology that works at the nano-scale to create lighter, stronger and more sustainable polymers. It does this by producing a cavitated structure that, in effect, replaces plastic with air. This reduces the amount of material needed to make commodity and bio-based plastics by up to 50%.
Dr Graeme Karney is the Chief Operating Officer for VOID, responsible for the company’s operations across North America and Europe. Graeme says that the SME Leaders programme has been useful in several ways: “The leadership training courses developed my thinking on negotiation and the dynamics of industry value chains. And the lessons learned from an experienced mentor helped to shape and clarify my approach to organisation management.”
In 2020, he relocated to Canada to oversee the group’s operations in the North America. In the same year, VOID secured £6 million of investment from two venture capital funds specialising in materials technology and petrochemicals. Now the company is hoping to work with film and packaging manufacturers to commercialise applications for VO+.
VO+ technology will enable manufacturers and retailers to significantly reduce plastic consumption and help them to achieve sustainability targets.
Diffblue Ltd is a University of Oxford spin-out company that combines artificial intelligence (AI) with software analysis to make coding more efficient and cost-effective. Diffblue Cover software uses AI to automatically write unit tests for Java code in minutes, a process that take days or weeks for a developer to write manually.
Peter Schrammel is the Co-Founder and CTO of Diffblue. Peter joined the SME Leaders programme in 2018 and has noticed the benefits. He says: “It has definitely sharpened my focus. I find I am able to more easily zoom in on the important elements of business. What I’ve learned on the programme has helped improve our organisation’s communications, both within the executive team and the company as a whole.”
Diffblue is disrupting traditional computer programming by helping developers automate their everyday tasks. Its software has been used by clients including Goldman Sachs and AWS, and operates through a paid subscription model. In September 2020, Diffblue launched its free community edition, which offers an IntelliJ plug-in with some of the paid features.
Diffblue aims to further revolutionise the programming process by using AI. In the future, its technology could even help developers to automatically correct and fix bugs in their systems - especially security bugs.
Loowatt designs and manufactures high quality, waterless flush toilets that could significantly improve access to adequate sanitation and hygiene where it is most needed. According to the World Health Organization and the United Nations Children’s Fund, 60% of the global population does not have access to safely managed sanitation, meaning that untreated waste from 4.3 billion people enters our environment every day. Loowatt toilets offer a safe and simple solution with a patented flushing technology that locks in odour and disease without using water or chemicals.
Virginia Gardiner, Founder and CEO, developed the technology and now leads the company in establishing a robust strategy and vision for growth. Loowatt has successfully generated revenue by operating toilets and waste processing in a range of contexts, from outdoor events in the UK to easy-to-install, outdoor toilets for homes in Madagascar. The company now aims to manufacture and sell universally-applicable, waterless flush toilets and sanitation solutions to a range of global markets.
Virginia aims to use training and support from the SME Leaders Programme to advance the company’s fundraising strategy as it develops plans to scale manufacturing processes and sell its products to international utilities.
Graphene has been dubbed the 21st century’s ‘super-material’. It is the most conductive material in existence, super-strong yet flexible and capable of resisting high electrical forces. However, until now, manufacturers had not been able to commercially exploit it successfully. In 2020, Paragraf Ltd took up the challenge and launched the GHS Series Hall-Effect sensor.
Paragraf’s direct-to-wafer manufacturing approach enables high purity graphene, with a high carrier mobility, to be integrated into sensing technologies. The GHS series of analogue sensors is designed to provide high-performance measurement, sensing and control for scientific research, healthcare, aerospace, industrial and automotive applications.
Dr Simon Thomas is the CEO of Paragraf Ltd. He became an SME Leader in 2018 and credits the programme with giving him “some fantastic learning opportunities. Thanks to these, I have grown significantly, both in terms of capability and as a person. The support of the Academy has helped me grow Paragraf into a strong and successful company.”
Paragraf has recently raised £16.2 million in series A funding and obtained several grants to investigate the replacement of rare and expensive metals in electronic devices. Now the company’s 50 staff are scaling up its commercial activities and maximising the reach of its products. It is now aiming to build strong partnerships that will enable it to bring graphene applications to a wider marketplace.
When Dr Daniel Tilley joined the SME leaders programme in 2018, he was leading the analytical science team at CyberOwl Ltd, developing products to support data risk management. CyberOwl works with companies to identify cyber security risks to their data systems by spotting suspicious or unsecure behaviour and unauthorised workarounds to security controls.
In 2020, Daniel set up his own company, Daniel Tilley Analytic Solutions, to work as an independent consultant in defence and cyber security. He credits the SME Leaders programme with helping him develop sufficient confidence to set up an independent consultancy, with the networking and mentoring opportunities being especially useful.
Daniel has experience in establishing statistical analysis systems of historical data, as well as building mathematical tools and prototypes. He has also supported military officers on training exercises helping quantify potential casualties and outcomes in conflict scenarios. This has led to other work in a variety of settings including an advisory role for a social enterprise group that builds up older people’s support groups to counter loneliness. His military expertise includes work representing human and environmental factors in combat models.
What makes us different is the Academy’s Fellows and our wider Mentor network – an unrivalled community of the UK’s most successful industry leaders, technology experts and entrepreneurs. Find out more about our Mentors and their areas of expertise.
Former Inaugural Chair of the Enterprise Committee and a long-standing Academy Fellow, Ian Shott CBE FREng has played a prominent role in establishing the Enterprise Hub. His track record of helping businesses in the engineering and life science sectors transform their approach and improve their vision, ambition, business models and enterprise value is an invaluable resource.
Ian is the Founder and former Executive Chair of contract pharmaceutical development and manufacturing company ARCINOVA, which he sold to Quotient Sciences in February 2021 and continues as Senior Advisor to the board. Ian is also the Managing Director at investment and advisory firm Shott Trinova. Prior to his specialist investment work at Shott Trinova, Ian was the founder and CEO of Excelsyn, which was sold to an American multinational in 2010. Earlier in his career he held numerous senior executive positions at multinational life science companies across the globe.
Ian has a wealth of experience with major industry bodies. He is formerly the Chair of the UK government’s Leadership Forum for Industrial Biotechnology and a Governing Board Member of Innovate UK. Ian is also Visiting Professor at Oxford, Nottingham and Newcastle universities.
“Apart from a deep-seated passion to change the entrepreneurial landscape in the UK and rediscover our legacy from the industrial revolution, I am highly excited by the prospect of engaging with new young talent and using my experience to accelerate and amplify their success. I’ve been involved in mentoring for over a decade but believe the Hub offers a very special opportunity to work with the brightest and best”.
Andy’s career in industry has involved co-founding over a dozen spin-outs and start-ups, three of which floated on stock markets. Virata floated on NASDAQ and at its peak had a market capitalisation of $5 billion.
His most prominent successes have come through RealVNC, which won the prestigious MacRobert Award in 2013, and Ubisense plc. Collectively, these two organisations have received five Queen’s Awards for Enterprise.
In academia, Andy heads the University of Cambridge’s Computer Laboratory and is an Honorary Fellow of Trinity Hall and Corpus Christi College. Elsewhere, he served as President of the IET between 2012 and 2013, and in 2007 received a CBE for services to the computer industry.
Andy is co-founder and Chairman of pioneering remote access software developers RealVNC and is also Professor of Computer Technology at the University of Cambridge. He was elected a Fellow of the Royal Academy of Engineering in 1996.
“My own career experiences have demonstrated just how important it is that the bridges between academia and industry are present and robust, and also what can be achieved when the relationship works to its potential. The Enterprise Hub offers an invaluable opportunity for exceptional academics to work with experienced industry figures and bring truly exciting new technology businesses to fruition.”
Naeem Alvi is an award-winning brand strategist and the founder of Notepad. After years of helping fast-growth SMEs and big brands such as Nike, Adidas and RBS Natwest to better leverage their brand, Naeem founded Notepad to connect big brand experience with ambitious tech companies that want to define and scale up their brands effectively and affordably.
Recent achievements include:
John is Professor of Optoelectronic Systems and Dean of transnational Education at the University of Glasgow.
He moved to Glasgow in 1986, where he established an internationally leading research group addressing linear and nonlinear integrated optoelectronic systems. He developed new integration technologies for photonic integrated circuits based on quantum well devices and quantum well intermixing, which ultimately led to the formation of the spin-out company Intense Ltd in 2000.
Intense developed the world’s most advanced integrated laser systems, bringing monolithic laser arrays together with electronic ASICs and optics for precise energy delivery in a range of applications from printing to material processing. The monolithic laser arrays pushed reliability and manufacturing yields to new levels.
John has extensive experience of operating in both academic and high-technology industrial environments, and as a result has an excellent understanding of spinning out IP and creating commercial value from an academic base.
He has been involved with several start-up companies including Kelvin Nanotechnology Ltd (1997-2000); Compound Semiconductor Technologies Ltd (1999-2000) and Intense Ltd (now Intense Inc) (2000-2009).
John was elected a Fellow of the Royal Academy of Engineering (FREng) in 2007; Fellow of the Royal Society of Edinburgh (FRSE) in 2000; Fellow of IEEE (FIEEE) in 2000 ‘for contributions to development of integrated optics based on semiconductor quantum well devices’; and Fellow of the Optical Society (FOSA) in 2016 for ‘for contributions to quantum and photonics technologies and systems in III-V compound semiconductors’.
Alastair is Head of Analytics and Machine Learning at MDRxTECH, Mishcon de Reya's digital transformation consultancy.
Alastair is a UCL Computer Science PhD with a background in computer vision, analytics, machine learning, blockchain, strategy, and technology innovation. He is an experienced manager and entrepreneur who has built teams in both large and small organisations. He is regularly called upon to audit, evaluate and provide guidance to large scale technology programmes for MDRxTECH clients. An entrepreneurial and dynamic problem solver, Alastair co-founded Satalia, which builds and applies AI technology to solve efficiency problems for organisations such as Tesco and PwC. He also co-founded the venture backed WeArePopUp.com, and helped establish the IDEALondon innovation centre with Cisco Systems.
Alastair continues to maintain an active teaching role in the UCL School of Management (MSc Business Analytics) and Peking University, Beijing (MBA Technology Strategy). His research interests include technology strategy, blockchain, smart contracting and computational law.
Brewster Barclay has been selling, marketing and product managing for more than 40 years in a wide variety of high technology industries including printed circuit boards, both manufacturing processes and capital equipment, 3D circuit boards, online advertising, optical sensors, military chip packaging, radar tubes and software engineering services. Brewster has worked at Zuhlke Engineering, e2v technologies, Clicktream Technologies, Orbotech and PCK Technology Kollmorgen.
The experience of launching new products and almost six years running an internet advertising startup led to Brewster giving back in the form of mentoring early stage and growth startups. He identified a massive gap in business development, sales support and strategy that angels, accelerators and VCs give to startups. He has focused solely on sharing his experiences in business development sales, sales techniques and the practicalities of day to day sales and lead generation.
He has mentored at the Royal Academy of Engineering for the past seven years as well as for Accelerate Cambridge, Seraphim Space Capital and many other groups.
Vida is a behavioural change coach with over seven years’ experience helping people think differently and positively change lives. She helps people to build connection and balance in order to create a sustainable future for themselves, others and the world. Vida does this as a speaker, trainer and coach, focusing on wellbeing, self-care, belief change, and motivation.
Having worked in prisons and schools as well as the public sector with non-clinical NHS staff and private sector for companies such Telefónica and Wavin, she has a unique insight to share.
Professor Alison Noble is the Technikos Professor of Biomedical Engineering, in the Department of Engineering Science at the University of Oxford, and Associate Head of MPLS Division. She is a Fellow of the Royal Society (2017), the Royal Academy of Engineering (2008) and the President of the Medical Image Computing and Computer Assisted Interventions (MICCAI) Society, the international society in biomedical image analysis.
Alison’s research interests are in computer analysis of clinical and biological images and the development and translation into clinical practice of novel methodologies that provide new diagnostic and therapeutic image based biomarkers and software tools for image-based quantification and decision-making. Her research group works in close collaboration with clinicians and industry players. She is also a Founder and the Chief Technology Officer of a university spin-out company that is commercialising research from her laboratory (Intelligent Ultrasound Ltd).
She returned to Oxford as a University Lecturer in 1995 to set up a biomedical image analysis group. Biomedical image analysis has since grown to be the largest biomedical engineering activity in Oxford.
Alison has played a leading role in setting up the biomedical engineering undergraduate and postgraduate biomedical engineering teaching and training (MSc and CDT) programmes at Oxford over the last decade. She is a member of both the Oxford University’s Research and Education Committees (from Oct 2013), and has served or currently serves on a number of committees of the Royal Academy of Engineering and other national organisations as well as numerous research funding agency panels.
Bill is a leading scientist worldwide in the field of Medical Materials. His major research contributions have been recognised by numerous international awards, medals and memberships.
He has been the Professor of Medical Materials at the University of Cambridge; served as Director of Cambridge Pfizer Institute for Pharmaceutical Materials Science; Cambridge Director of CMI Interdisciplinary Research Cluster in Biomaterials and Tissue Engineering and Director of University of London Interdisciplinary Research Centre (IRC) in Biomedical Materials. He has been Head of Department, Dean, and Governor at Queen Mary University of London.
He has been the editor of the Journal of The Royal Society: Interface, the Journal of Materials Science: Materials in Medicine, the Journal of Materials Science, and of the Journal of Materials Science Letters.
Bill is Emeritus Professor of Medical Materials in the University of Cambridge. He is internationally recognised for his pioneering research contributions to biomaterials for medical devices, with awards including the Royal Academy of Engineering Prince Philip Gold Medal; the Royal Society Armourers and Brasiers Company Medal; the Kelvin Medal; the European Society for Biomaterials George Winter Award; the Japanese Society for Biomaterials Medal; the Institute of Materials Griffiths Medal and Chapman Medal; the UK Society for Biomaterials President's Prize; the Acta Metallurgica H.H. Holloman Award and the International Union for Physical Sciences and Engineering in Medicine Award of Merit.
Professor Bonfield's exceptional interdisciplinary contribution has been recognised by his election to all three UK National Academies as a Fellow of the Royal Society (FRS), a Fellow of the Royal Academy of Engineering (FREng) and a Fellow of the Academy of Medical Sciences (FMedSci).